Presentation is loading. Please wait.

Presentation is loading. Please wait.

Randomized comparison of new dual-antiplatelet therapy (aspirin, prasugrel) and triple- antiplatelet therapy (aspirin, clopidogrel, cilostazol) using P2Y12.

Similar presentations


Presentation on theme: "Randomized comparison of new dual-antiplatelet therapy (aspirin, prasugrel) and triple- antiplatelet therapy (aspirin, clopidogrel, cilostazol) using P2Y12."— Presentation transcript:

1 Randomized comparison of new dual-antiplatelet therapy (aspirin, prasugrel) and triple- antiplatelet therapy (aspirin, clopidogrel, cilostazol) using P2Y12 point-of-care assay in patients with STEMI undergoing primary PCI  Tae-Hyun Yang, Han-Young Jin, Kyu-Nam Choi, Ungjeong Do, Hyung Jun Kim, Sang-Ryul Chung, Jeong-Sook Seo, Jae-Sik Jang, Dae- Kyeong Kim, Dong-Soo Kim  International Journal of Cardiology  Volume 168, Issue 1, Pages (September 2013) DOI: /j.ijcard Copyright © 2012 Elsevier Ireland Ltd Terms and Conditions

2 Fig. 1 Schematic of study design.
International Journal of Cardiology  , DOI: ( /j.ijcard ) Copyright © 2012 Elsevier Ireland Ltd Terms and Conditions

3 Fig. 2 Serial change of P2Y12 reaction unit values.
International Journal of Cardiology  , DOI: ( /j.ijcard ) Copyright © 2012 Elsevier Ireland Ltd Terms and Conditions

4 Fig. 3 P2Y12 reaction unit values at discharge.
International Journal of Cardiology  , DOI: ( /j.ijcard ) Copyright © 2012 Elsevier Ireland Ltd Terms and Conditions

5 Fig. 4 Individual P2Y12 reaction unit values according to treatment. Lines represent medians. International Journal of Cardiology  , DOI: ( /j.ijcard ) Copyright © 2012 Elsevier Ireland Ltd Terms and Conditions


Download ppt "Randomized comparison of new dual-antiplatelet therapy (aspirin, prasugrel) and triple- antiplatelet therapy (aspirin, clopidogrel, cilostazol) using P2Y12."

Similar presentations


Ads by Google